Lifeboat Foundation

Intelligent systems engineer, STEM advocate, hip-hop artist — ashley llorens, VP, distinguished scientist, managing director microsoft research, microsoft.

Ashley Llorens (https://www.microsoft.com/en-us/research/people/allorens/) is Vice President, Distinguished Scientist & Managing Director, at Microsoft Research Outreach, where he leads a global team to amplify the impact of research at Microsoft and to advance the cause of science and technology research around the world. His team is responsible for driving strategy and execution for Microsoft Research engagement with the rest of Microsoft and with the broader science and technology community, and they invest in high-impact collaborative research projects on behalf of the company, create pipelines for diverse, world-class talent, and generate awareness of the current and envisioned future impact of science and technology research.

Continue reading “Ashley Llorens — VP, Distinguished Scientist & Managing Director, Microsoft Research Outreach” »

By Susan Ip-Jewell## **Space Medicine, Health and MedTech Innovations, a lecture by Susan Ip-Jewell**

In the frame of the new Space Renaissance Academy Webinar Series programme, chaired by the optimum Sabine Heinz, a quite interesting and rich lecture was given yesterday by Dr. Susan Ip Jewell.

Continue reading “Space Medicine, Health and MedTech Innovations, a lecture” »

Quick vid and a reminder of the 4th conference of Lifespan.io is this weekend.

Gene editing can make stem cells invisible to the immune system, making it possible to carry out cell therapy transplants without suppressing the patients’ immune response. Scientists in the US and Germany used immune engineering to develop universal cell products that could be used in all transplant patients. The idea is to create stem cells that evade the immune system; these hypoimmune stem cells are then used to generate cells of the desired type that can be transplanted into any patient without the need for immunosuppression, since the cells won’t elicit an immune response. They used CRISPR-Cas9 to knock out two genes involved in the major histocompatibility complex, which is used for self/non-self discrimination. They also increased the expression of a protein that acts as a “don’t eat me” signal to protect cells from macrophages. Together, these changes made the stem cells look less foreign and avoid clearance by macrophages. The team then differentiated endothelial cells and cardiomyocytes from the engineered stem cells, and they used these to treat three different diseases in mice. Cell therapy treatments using the hypoimmune cells were effective in rescuing hindlimbs from vascular blockage, preventing lung damage in an engineered mouse model, and maintaining heart function following a myocardial infarction. Immunosuppression poses obvious risks to a patient, and generating custom cells for transplant therapy is often prohibitively expensive. The development of universal donor cells that can be used as therapeutics could bring the cost down significantly, making cellular therapeutics available to many more patients in a much safer way.

Continue reading “CRISPR Development Makes Stem Cells ‘Invisible’ to Immune System Without Immunosuppressants” »

There’s a lot that scientists still don’t understand about pterosaurs, CNET reports, especially because so few fossils have been found. But uncovering this new fossil helps explain how the admittedly terrifying creature lived, hunted, and flourished millions of years ago.

The fossil — a massive jawbone — suggests that the Thapunngaka shawi was a ferocious hunter. The 3.2 foot-long jaw likely held as many as 40 huge, sharp teeth. The creature had a wingspan of 22 feet and a neck longer than a giraffe’s that it used to balance its humongous head, according to CNET.

“This thing would have been quite savage,” study coauthor and University of Queensland School of Biological Sciences PhD student Tim Richards told the site. “It would have cast a great shadow over some quivering little dinosaur that wouldn’t have heard it until it was too late.”

Seeing is believing.

Jeff Bezos’s Blue Origin is challenging a U.S. government contract with Elon Musk’s SpaceX to develop technology to land people on the moon again.

In a complaint filed Friday in the Court of Federal Claims in Washington, Blue Origin said the National Aeronautics and Space Administration’s evaluation process was “unlawful and improper.” The complaint was filed under seal but tandem documents seeking a protective order gave an indication of its contents.

NASA selected SpaceX’s human lander bid on April 16 leading Blue Origin and a bidding partner, Dynetics Inc., to file protests with the Government Accountability Office less than two weeks later alleging that the award process was flawed. The GAO denied that protest on July 30 saying that NASA’s SpaceX selection had been made properly. Blue Origin, which has offered to contribute more than $2 billion of work on the project at no cost to the government, had vowed to continue pursuing the matter.

SpaceX is gearing up to launch the Starship into orbit, the biggest test yet for the ship designed to send humans to Mars and beyond.

O,., o!!!!!! That is some real Ironman stuff.

Building on OpenAI’s Codex system, CodeVox turns spoken, natural language into lines of code.

Mazda is developing a hydrogen-burning rotary engine, according to a recent report. It could build a prototype by the middle of the 2020s.